Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective…

Overview of attention for article published in Lancet Oncology, January 2026

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Above-average Attention Score compared to outputs of the same age and source (64th percentile)

Mentioned by

news: 3 news outlets
twitter: 13 X users

facebook: 1 Facebook page
guideline: 1 clinical guideline source

Readers on

mendeley: 29 Mendeley

So far, Altmetric has seen 14 X posts from 13 X users, with an upper bound of 20,136 followers.

RT @MTCanningMD: @TumorBoardTues @gandhi_shipra @IntegrityCE @stolaney1 @dradityabardia @Prof_Nadia_H @EMittendorfMD 25/31 #TumorBoardTuesd…

@TumorBoardTues @gandhi_shipra @IntegrityCE @stolaney1 @dradityabardia @Prof_Nadia_H @EMittendorfMD 25/31 #TumorBoardTuesday 💡ALND + RNI remains SOC for residual nodal dz after neoadj tx. 👏The OPBC-07/microNAC study continues to show benefit of ALND in …

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 10 additional X posts.